Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Spironolactone plus finasteride works better for treating hirsutism.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.